Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth J Pienta

Showing results (271-280 of 519) with videos related to

Pageof 52
Sort By:
Cancer Research|April 19, 2007
An imaging biomarker of early treatment response in prostate cancer that has metastasized to the boneKuei C Lee, Sudha Sud, Charles R Meyer, et al.
Nature Reviews. Urology|November 28, 2018
Prostate-specific markers to identify rare prostate cancer cells in liquid biopsiesEmma E van der Toom, Haley D Axelrod, Jean J de la Rosette, et al.
Neoplasia (New York, N.Y.)|February 23, 2012
Inhibition of prostate cancer bone metastasis by synthetic TF antigen mimic/galectin-3 inhibitor lactulose-L-leucineOlga V Glinskii, Sudha Sud, Valeri V Mossine, et al.
Neoplasia (New York, N.Y.)|November 3, 2009
The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitmentKosuke Mizutani, Sudha Sud, Natalie A McGregor, et al.
American Journal of Clinical and Experimental Urology|May 11, 2023
Novel urinary tract obstruction marker discovery by multi-marker profiling of urinary extracellular vesicles derived from a rat UTO modelNora M Haney, Chi-Ju Kim, Morgan D Kuczler, et al.
The Prostate|March 14, 2022
<sup>177</sup> Lu-PSMA radioligand therapy effectiveness in metastatic castration-resistant prostate cancer: An updated systematic review and meta-analysisMohammad S Sadaghiani, Sara Sheikhbahaei, Rudolf A Werner, et al.
The Prostate|April 6, 2004
In vivo real-time imaging of TGF-beta-induced transcriptional activation of the RANK ligand gene promoter in intraosseous prostate cancerJian Zhang, Yi Lu, Jinlu Dai, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|October 9, 2004
Apoptosis of circulating tumor cells in prostate cancer patientsChristopher J Larson, Jose G Moreno, Kenneth J Pienta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2003
The role of an 80 kDa fragment of E-cadherin in the metastatic progression of prostate cancerRainer Kuefer, Matthias D Hofer, Juergen E Gschwend, et al.
Journal of Cellular Biochemistry|July 30, 2005
PAR1-mediated NFkappaB activation promotes survival of prostate cancer cells through a Bcl-xL-dependent mechanismKwanchanit Tantivejkul, Robert D Loberg, Samkeliso C Mawocha, et al.
Pageof 52

Showing results (271-280 of 519) with videos related to

Sort By:
Pageof 52
Cancer Research|April 19, 2007
An imaging biomarker of early treatment response in prostate cancer that has metastasized to the boneKuei C Lee, Sudha Sud, Charles R Meyer, et al.
Nature Reviews. Urology|November 28, 2018
Prostate-specific markers to identify rare prostate cancer cells in liquid biopsiesEmma E van der Toom, Haley D Axelrod, Jean J de la Rosette, et al.
Neoplasia (New York, N.Y.)|February 23, 2012
Inhibition of prostate cancer bone metastasis by synthetic TF antigen mimic/galectin-3 inhibitor lactulose-L-leucineOlga V Glinskii, Sudha Sud, Valeri V Mossine, et al.
Neoplasia (New York, N.Y.)|November 3, 2009
The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitmentKosuke Mizutani, Sudha Sud, Natalie A McGregor, et al.
American Journal of Clinical and Experimental Urology|May 11, 2023
Novel urinary tract obstruction marker discovery by multi-marker profiling of urinary extracellular vesicles derived from a rat UTO modelNora M Haney, Chi-Ju Kim, Morgan D Kuczler, et al.
The Prostate|March 14, 2022
<sup>177</sup> Lu-PSMA radioligand therapy effectiveness in metastatic castration-resistant prostate cancer: An updated systematic review and meta-analysisMohammad S Sadaghiani, Sara Sheikhbahaei, Rudolf A Werner, et al.
The Prostate|April 6, 2004
In vivo real-time imaging of TGF-beta-induced transcriptional activation of the RANK ligand gene promoter in intraosseous prostate cancerJian Zhang, Yi Lu, Jinlu Dai, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|October 9, 2004
Apoptosis of circulating tumor cells in prostate cancer patientsChristopher J Larson, Jose G Moreno, Kenneth J Pienta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2003
The role of an 80 kDa fragment of E-cadherin in the metastatic progression of prostate cancerRainer Kuefer, Matthias D Hofer, Juergen E Gschwend, et al.
Journal of Cellular Biochemistry|July 30, 2005
PAR1-mediated NFkappaB activation promotes survival of prostate cancer cells through a Bcl-xL-dependent mechanismKwanchanit Tantivejkul, Robert D Loberg, Samkeliso C Mawocha, et al.
Pageof 52